US Stem Cell Inc (USRM)

[Dragon Lady]

PRICE DOWN 70%, common stock from March 6th, to today (about 6 weeks). DOWN 99.40% from Feb 19th, 2009 to today.

Common stock shares massively diluted from 27,327,705 shares as of only June 30, 2010 to now 420,920,157 as of March 24, 2014.

And still, some call this a $billion "opportunity" or company and say "management is doing a great job" or whatever, blah, blah, blah.

By any generally accepted business metric, performance metric that I'm familiar with out there, this is a total, abject business failure by any measure anyone wants to use IMO.

AND, despite all that- the two key players in the company, just, essentially tripled their own compensation packages recently. One, the CEO, to a total annual compensation approaching $1 MILLION annually (while the total market cap is now $10.5 million, and the company is buried in debt and near out of cash- making it essentially worthless IMO)- that's laughable IMO. AND, that includes "bonuses"?? Bonuses FOR DOING WHAT?
(see most recent 10-K, PAGE 71)

If this doesn't smell bad to people, then they must be "hard of smelling" IMHO.